Free for academic non-profit institutions. Other users need a Commercial license

Aliases for LMNA Gene

Aliases for LMNA Gene

  • Lamin A/C 2 3
  • LMN1 3 4 6
  • Lamin A/C-Like 1 2 3
  • LGMD1B 3 6
  • FPLD2 3 6
  • CMD1A 3 6
  • HGPS 3 6
  • EMD2 3 6
  • Limb Girdle Muscular Dystrophy 1B (Autosomal Dominant) 2
  • Cardiomyopathy, Dilated 1A (Autosomal Dominant) 2
  • Progeria 1 (Hutchinson-Gilford Type) 2
  • Renal Carcinoma Antigen NY-REN-32 3
  • 70 KDa Lamin 3
  • Prelamin-A/C 3
  • CMT2B1 3
  • CDCD1 3
  • Lamin 3
  • LMNL1 3
  • PRO1 3
  • CDDC 3
  • FPLD 3
  • LDP1 3
  • LMNC 3
  • FPL 3
  • IDC 3
  • LFP 3

External Ids for LMNA Gene

Previous HGNC Symbols for LMNA Gene

  • LMN1
  • CMD1A
  • LGMD1B
  • PRO1
  • LMNL1

Previous GeneCards Identifiers for LMNA Gene

  • GC01P153921
  • GC01P151817
  • GC01P152830
  • GC01P153301
  • GC01P152897
  • GC01P154318
  • GC01P156053
  • GC01P127446

Summaries for LMNA Gene

Entrez Gene Summary for LMNA Gene

  • The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012]

GeneCards Summary for LMNA Gene

LMNA (Lamin A/C) is a Protein Coding gene. Diseases associated with LMNA include cardiomyopathy, dilated, 1a and muscular dystrophy, limb-girdle, type 1b. Among its related pathways are Cell Cycle, Mitotic and Cell Cycle, Mitotic. GO annotations related to this gene include structural molecule activity. An important paralog of this gene is LMNB2.

UniProtKB/Swiss-Prot for LMNA Gene

  • Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation. Required for osteoblastogenesis and bone formation. Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone

  • Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence

Gene Wiki entry for LMNA Gene

No data available for Tocris Summary , PharmGKB "VIP" Summary , fRNAdb sequence ontologies and piRNA Summary for LMNA Gene

Genomics for LMNA Gene

Regulatory Elements for LMNA Gene

Genomic Location for LMNA Gene

Start:
156,082,546 bp from pter
End:
156,140,089 bp from pter
Size:
57,544 bases
Orientation:
Plus strand

Genomic View for LMNA Gene

UCSC Golden Path with GeneCards custom track
Cytogenetic band:
Genomic Location for LMNA Gene
GeneLoc Logo Genomic Neighborhood Exon StructureGene Density

RefSeq DNA sequence for LMNA Gene

Proteins for LMNA Gene

  • Protein details for LMNA Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    P02545-LMNA_HUMAN
    Recommended name:
    Prelamin-A/C
    Protein Accession:
    P02545
    Secondary Accessions:
    • B4DI32
    • D3DVB0
    • D6RAQ3
    • E7EUI9
    • P02546
    • Q5I6Y4
    • Q5I6Y6
    • Q5TCJ2
    • Q5TCJ3
    • Q6UYC3
    • Q969I8
    • Q96JA2

    Protein attributes for LMNA Gene

    Size:
    664 amino acids
    Molecular mass:
    74139 Da
    Quaternary structure:
    • Homodimer of lamin A and lamin C. Interacts with lamin-associated polypeptides IA, IB and TMPO-alpha, RB1 and with emerin. Interacts with SREBF1, SREBF2, SUN2 and TMEM43 (By similarity). Proteolytically processed isoform A interacts with NARF. Interacts with SUN1. Prelamin-A/C interacts with EMD. Interacts with MLIP; may regulate MLIP localization to the nucleus envelope. Interacts with DMPK; may regulate nuclear envelope stability. Interacts with SUV39H1; the interaction increases stability of SUV39H1. Interacts with SYNE2.
    Miscellaneous:
    • The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively
    • There are three types of lamins in human cells: A, B, and C
    SequenceCaution:
    • Sequence=CAA27173.1; Type=Frameshift; Positions=582; Evidence={ECO:0000305};

    Three dimensional structures from OCA and Proteopedia for LMNA Gene

    Alternative splice isoforms for LMNA Gene

neXtProt entry for LMNA Gene

Proteomics data for LMNA Gene at MOPED

Post-translational modifications for LMNA Gene

  • Farnesylation of prelamin-A/C facilitates nuclear envelope targeting
  • Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.
  • Proteolytic cleavage of the C-terminal of 18 residues of prelamin-A/C results in the production of lamin-A/C. The prelamin-A/C maturation pathway includes farnesylation of CAAX motif, ZMPSTE24/FACE1 mediated cleavage of the last three amino acids, methylation of the C-terminal cysteine and endoproteolytic removal of the last 15 C-terminal amino acids. Proteolytic cleavage requires prior farnesylation and methylation, and absence of these blocks cleavage.
  • Sumoylation is necessary for the localization to the nuclear envelope.
  • Ubiquitination at Lys78, Lys108, Lys135, Lys144, Lys171, Lys181, Lys201, Lys208, Lys265, Lys270, Lys311, Lys378, Lys470, and Lys486
  • Modification sites at PhosphoSitePlus

No data available for DME Specific Peptides for LMNA Gene

Domains for LMNA Gene

Gene Families for LMNA Gene

HGNC:
  • IFF5 :Intermediate filaments type V, lamins

Graphical View of Domain Structure for InterPro Entry

P02545

UniProtKB/Swiss-Prot:

LMNA_HUMAN :
  • P02545
Domain:
  • Contains 1 LTD domain.
Family:
  • Belongs to the intermediate filament family.
genes like me logo Genes that share domains with LMNA: view

Function for LMNA Gene

Molecular function for LMNA Gene

GENATLAS Biochemistry: lamin,types A and C,common gene,alternatively spliced isoforms
UniProtKB/Swiss-Prot Function: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation. Required for osteoblastogenesis and bone formation. Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone
UniProtKB/Swiss-Prot Function: Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence

Gene Ontology (GO) - Molecular Function for LMNA Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0005198 structural molecule activity TAS 3453101
GO:0005515 protein binding IPI 10381623
genes like me logo Genes that share ontologies with LMNA: view
genes like me logo Genes that share phenotypes with LMNA: view

Animal Models for LMNA Gene

MGI Knock Outs for LMNA:

No data available for Enzyme Numbers (IUBMB) , Transcription Factor Targeting and HOMER Transcription for LMNA Gene

Localization for LMNA Gene

Subcellular locations from UniProtKB/Swiss-Prot for LMNA Gene

Nucleus. Nucleus envelope. Nucleus lamina. Nucleus, nucleoplasm. Note=Farnesylation of prelamin-A/C facilitates nuclear envelope targeting and subsequent cleaveage by ZMPSTE24/FACE1 to remove the farnesyl group produces mature lamin-A/C, which can then be inserted into the nuclear lamina. EMD is required for proper localization of non-farnesylated prelamin-A/C.
Isoform C: Nucleus speckle.

Subcellular locations from

COMPARTMENTS
Jensen Localization Image for LMNA Gene COMPARTMENTS Subcellular localization image for LMNA gene
Compartment Confidence
nucleus 5
cytosol 4
cytoskeleton 2
extracellular 1
mitochondrion 1
plasma membrane 1

Gene Ontology (GO) - Cellular Components for LMNA Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0005634 nucleus IDA --
GO:0005635 nuclear envelope TAS 3453101
GO:0005638 lamin filament TAS 10080180
GO:0005652 nuclear lamina TAS 8344919
GO:0005654 nucleoplasm TAS --
genes like me logo Genes that share ontologies with LMNA: view

Pathways for LMNA Gene

genes like me logo Genes that share pathways with LMNA: view

Gene Ontology (GO) - Biological Process for LMNA Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000278 mitotic cell cycle TAS --
GO:0006915 apoptotic process TAS --
GO:0006921 cellular component disassembly involved in execution phase of apoptosis TAS --
GO:0006987 activation of signaling protein activity involved in unfolded protein response --
GO:0006997 nucleus organization --
genes like me logo Genes that share ontologies with LMNA: view

Compounds for LMNA Gene

(18) Novoseek inferred chemical compound relationships for LMNA Gene

Compound -log(P) Hits PubMed IDs
nelfinavir 23.7 2
rosiglitazone 18 2
indinavir 17.1 3
zinc 14.2 7
retinoic acid 12.4 13
genes like me logo Genes that share compounds with LMNA: view

Transcripts for LMNA Gene

Unigene Clusters for LMNA Gene

Lamin A/C:
Representative Sequences:

Alternative Splicing Database (ASD) splice patterns (SP) for LMNA Gene

ExUns: 1a · 1b ^ 2 ^ 3 ^ 4a · 4b ^ 5 ^ 6a · 6b ^ 7 ^ 8 ^ 9 ^ 10a · 10b ^ 11a · 11b ^ 12a · 12b · 12c
SP1: - -
SP2: - - -
SP3: -
SP4:

Relevant External Links for LMNA Gene

GeneLoc Exon Structure for
LMNA
ECgene alternative splicing isoforms for
LMNA

Expression for LMNA Gene

mRNA expression in normal human tissues for LMNA Gene

mRNA expression in embryonic tissues and stem cells from LifeMap Discovery

Integrated Proteomics: protein expression from ProteomicsDB, PaxDb, MOPED, and MaxQB for LMNA Gene

SOURCE GeneReport for Unigene cluster for LMNA Gene Hs.594444

mRNA Expression by UniProt/SwissProt for LMNA Gene

P02545-LMNA_HUMAN
Tissue specificity: In the arteries, prelamin-A/C accumulation is not observed in young healthy vessels but is prevalent in medial vascular smooth muscle cells (VSMCs) from aged individuals and in atherosclerotic lesions, where it often colocalizes with senescent and degenerate VSMCs. Prelamin-A/C expression increases with age and disease. In normal aging, the accumulation of prelamin-A/C is caused in part by the down-regulation of ZMPSTE24/FACE1 in response to oxidative stress.
genes like me logo Genes that share expressions with LMNA: view

No data available for mRNA differential expression in normal tissues for LMNA Gene

Orthologs for LMNA Gene

This gene was present in the common ancestor of animals.

Orthologs for LMNA Gene

Organism Taxonomy Gene Similarity Type Details
chimpanzee
(Pan troglodytes)
Mammalia LMNA 35
  • 99.65 (n)
  • 99.7 (a)
LMNA 36
  • 100 (a)
OneToOne
cow
(Bos Taurus)
Mammalia LMNA 35
  • 92.55 (n)
  • 98.06 (a)
LMNA 36
  • 98 (a)
OneToOne
dog
(Canis familiaris)
Mammalia LMNA 35
  • 92.67 (n)
  • 97.59 (a)
LMNA 36
  • 98 (a)
OneToOne
mouse
(Mus musculus)
Mammalia Lmna 35
  • 90.15 (n)
  • 96.53 (a)
Lmna 16
Lmna 36
  • 97 (a)
OneToOne
oppossum
(Monodelphis domestica)
Mammalia LMNA 36
  • 91 (a)
OneToOne
platypus
(Ornithorhynchus anatinus)
Mammalia LMNA 36
  • 91 (a)
OneToOne
rat
(Rattus norvegicus)
Mammalia Lmna 35
  • 83.59 (n)
  • 88.03 (a)
chicken
(Gallus gallus)
Aves -- 36
  • 47 (a)
ManyToMany
lizard
(Anolis carolinensis)
Reptilia -- 36
  • 57 (a)
OneToMany
-- 36
  • 67 (a)
OneToMany
African clawed frog
(Xenopus laevis)
Amphibia lmna-A 35
tropical clawed frog
(Silurana tropicalis)
Amphibia lmna 35
  • 72.74 (n)
  • 74.2 (a)
zebrafish
(Danio rerio)
Actinopterygii lmna 35
  • 66.72 (n)
  • 67.93 (a)
lmna 36
  • 66 (a)
OneToOne
African malaria mosquito
(Anopheles gambiae)
Insecta AgaP_AGAP008015 35
  • 51.67 (n)
  • 37.87 (a)
fruit fly
(Drosophila melanogaster)
Insecta Lam 36
  • 35 (a)
ManyToMany
LamC 36
  • 33 (a)
ManyToMany
LamC 37
  • 37 (a)
Lam 37
  • 37 (a)
worm
(Caenorhabditis elegans)
Secernentea lmn-1 36
  • 29 (a)
OneToMany
ifa-2 37
  • 27 (a)
ifb-1 37
  • 29 (a)
ifb-2 37
  • 25 (a)
lmn-1 37
  • 30 (a)
ifa-4 37
  • 27 (a)
sea squirt
(Ciona savignyi)
Ascidiacea CSA.8283 36
  • 34 (a)
OneToMany
Species with no ortholog for LMNA:
  • A. gosspyii yeast (Ashbya gossypii)
  • Actinobacteria (Mycobacterium tuberculosis)
  • Alicante grape (Vitis vinifera)
  • alpha proteobacteria (Wolbachia pipientis)
  • amoeba (Dictyostelium discoideum)
  • Archea (Pyrococcus horikoshii)
  • baker's yeast (Saccharomyces cerevisiae)
  • barley (Hordeum vulgare)
  • beta proteobacteria (Neisseria meningitidis)
  • bread mold (Neurospora crassa)
  • Chromalveolata (Phytophthora infestans)
  • common water flea (Daphnia pulex)
  • corn (Zea mays)
  • E. coli (Escherichia coli)
  • filamentous fungi (Aspergillus nidulans)
  • Firmicute bacteria (Streptococcus pneumoniae)
  • fission yeast (Schizosaccharomyces pombe)
  • green algae (Chlamydomonas reinhardtii)
  • honey bee (Apis mellifera)
  • K. lactis yeast (Kluyveromyces lactis)
  • loblloly pine (Pinus taeda)
  • malaria parasite (Plasmodium falciparum)
  • medicago trunc (Medicago Truncatula)
  • moss (Physcomitrella patens)
  • orangutan (Pongo pygmaeus)
  • pig (Sus scrofa)
  • rainbow trout (Oncorhynchus mykiss)
  • rice (Oryza sativa)
  • rice blast fungus (Magnaporthe grisea)
  • schistosome parasite (Schistosoma mansoni)
  • sea anemone (Nematostella vectensis)
  • sea urchin (Strongylocentrotus purpuratus)
  • sorghum (Sorghum bicolor)
  • soybean (Glycine max)
  • stem rust fungus (Puccinia graminis)
  • sugarcane (Saccharum officinarum)
  • thale cress (Arabidopsis thaliana)
  • tomato (Lycopersicon esculentum)
  • toxoplasmosis (Toxoplasma gondii)
  • Trichoplax (Trichoplax adhaerens)
  • wheat (Triticum aestivum)

Evolution for LMNA Gene

ENSEMBL:
Gene Tree for LMNA (if available)
TreeFam:
Gene Tree for LMNA (if available)

Paralogs for LMNA Gene

Paralogs for LMNA Gene

Selected SIMAP similar genes for LMNA Gene using alignment to 5 proteins:

genes like me logo Genes that share paralogs with LMNA: view

Variants for LMNA Gene

Sequence variations from dbSNP and Humsavar for LMNA Gene

SNP ID Clin Chr 01 pos Sequence Context AA Info Type MAF
rs4641 other 156,137,743(+) CACCA(C/T)GTGAG reference, synonymous-codon, intron-variant
rs7339 untested 156,139,185(-) CATGA(C/G)GTGCA intron-variant, utr-variant-3-prime
rs13768 untested 156,138,660(+) CACTC(A/G/T)CAGCT missense, reference, intron-variant
rs15292 -- 156,140,021(+) CTTGC(C/T)TCCCC utr-variant-3-prime
rs471679 -- 156,125,652(-) gagta(C/G)agtgg upstream-variant-2KB, intron-variant

Structural Variations from Database of Genomic Variants (DGV) for LMNA Gene

Variant ID Type Subtype PubMed ID
nsv509513 CNV Insertion 20534489

Relevant External Links for LMNA Gene

HapMap Linkage Disequilibrium report
LMNA
Human Gene Mutation Database (HGMD)
LMNA
Locus Specific Mutation Databases (LSDB)
LMNA

No data available for Polymorphic Variants from UniProtKB/Swiss-Prot for LMNA Gene

Disorders for LMNA Gene

(11) OMIM Diseases for LMNA Gene (150330)

UniProtKB/Swiss-Prot

LMNA_HUMAN
  • Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269 PubMed:10080180, ECO:0000269 PubMed:10739764, ECO:0000269 PubMed:10908904, ECO:0000269 PubMed:10939567, ECO:0000269 PubMed:11503164, ECO:0000269 PubMed:12032588, ECO:0000269 PubMed:12649505, ECO:0000269 PubMed:14684700, ECO:0000269 PubMed:14985400, ECO:0000269 PubMed:15744034, ECO:0000269 PubMed:20848652}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269 PubMed:22431096}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269 PubMed:10580070, ECO:0000269 PubMed:11561226, ECO:0000269 PubMed:11897440, ECO:0000269 PubMed:12486434, ECO:0000269 PubMed:12628721, ECO:0000269 PubMed:12920062, ECO:0000269 PubMed:14684700, ECO:0000269 PubMed:15140538, ECO:0000269 PubMed:15219508, ECO:0000269 PubMed:16061563, ECO:0000269 PubMed:20160190, ECO:0000269 PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]: A disorder characterized by the loss of subcutaneous adipose tissue in the lower parts of the body (limbs, buttocks, trunk). It is accompanied by an accumulation of adipose tissue in the face and neck causing a double chin, fat neck, or cushingoid appearance. Adipose tissue may also accumulate in the axillae, back, labia majora, and intraabdominal region. Affected patients are insulin-resistant and may develop glucose intolerance and diabetes mellitus after age 20 years, hypertriglyceridemia, and low levels of high density lipoprotein cholesterol. {ECO:0000269 PubMed:10587585, ECO:0000269 PubMed:10655060, ECO:0000269 PubMed:10739751, ECO:0000269 PubMed:12015247, ECO:0000269 PubMed:12196663, ECO:0000269 PubMed:12629077, ECO:0000269 PubMed:17250669, ECO:0000269 PubMed:24485160}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Limb-girdle muscular dystrophy 1B (LGMD1B) [MIM:159001]: An autosomal dominant degenerative myopathy with age-related atrioventricular cardiac conduction disturbances, dilated cardiomyopathy, and the absence of early contractures. Characterized by slowly progressive skeletal muscle weakness of the hip and shoulder girdles. Muscle biopsy shows mild dystrophic changes. {ECO:0000269 PubMed:10814726, ECO:0000269 PubMed:11525883, ECO:0000269 PubMed:12032588, ECO:0000269 PubMed:12673789, ECO:0000269 PubMed:15744034, ECO:0000269 PubMed:17136397}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Charcot-Marie-Tooth disease 2B1 (CMT2B1) [MIM:605588]: A recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced. {ECO:0000269 PubMed:11799477}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]: Rare genetic disorder characterized by features reminiscent of marked premature aging. {ECO:0000269 PubMed:12714972, ECO:0000269 PubMed:12768443, ECO:0000269 PubMed:12927431, ECO:0000269 PubMed:15286156, ECO:0000269 PubMed:15622532, ECO:0000269 PubMed:21791255}. Note=The disease is caused by mutations affecting the gene represented in this entry. HGPS is caused by the toxic accumulation of a truncated form of lamin-A/C. This mutant protein, called progerin (isoform 6), acts to deregulate mitosis and DNA damage signaling, leading to premature cell death and senescence. The mutant form is mainly generated by a silent or missense mutation at codon 608 of prelamin A that causes activation of a cryptic splice donor site, resulting in production of isoform 6 with a deletion of 50 amino acids near the C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage site and therefore remains permanently farnesylated. Thus, although it can enter the nucleus and associate with the nuclear envelope, it cannot incorporate normally into the nuclear lamina (PubMed:12714972). {ECO:0000269 PubMed:12714972}.
  • Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112]: A disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. {ECO:0000269 PubMed:12927431, ECO:0000269 PubMed:17150192, ECO:0000269 PubMed:19283854}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]: A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, progeroid appearance, partial alopecia, soft tissue calcinosis, joint contractures, and partial lipodystrophy with loss of subcutaneous fat from the extremities. Adipose tissue in the face, neck and trunk is normal or increased. {ECO:0000269 PubMed:12075506, ECO:0000269 PubMed:15998779, ECO:0000269 PubMed:16278265}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]: Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance. {ECO:0000269 PubMed:15317753}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Heart-hand syndrome Slovenian type (HHS-Slovenian) [MIM:610140]: Heart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and limb malformations. {ECO:0000269 PubMed:18611980}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]: A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures. {ECO:0000269 PubMed:18551513}. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Note=Defects in LMNA may cause a late-onset cardiocutaneous progeria syndrome characterized by cutaneous manifestations of aging appearing in the third decade of life, cardiac valve calcification and dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to death on average in the fourth decade. {ECO:0000269 PubMed:23666920}.

(73) Novoseek inferred disease relationships for LMNA Gene

Disease -log(P) Hits PubMed IDs
lipodystrophy, familial partial 97.8 72
progeria 97 66
muscular dystrophy emery-dreifuss 96.5 43
emery-dreifuss muscular dystrophy, autosomal dominant 96.4 19
lgmd1b 95.4 21

Relevant External Links for LMNA

GeneTests
LMNA
GeneReviews
LMNA
Genetic Association Database (GAD)
LMNA
Human Genome Epidemiology (HuGE) Navigator
LMNA
genes like me logo Genes that share disorders with LMNA: view

Publications for LMNA Gene

  1. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. (PMID: 12920062) Sebillon P. … Komajda M. (J. Med. Genet. 2003) 3 4 23 48
  2. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. (PMID: 15219508) Hermida-Prieto M. … Crespo-Leiro M. (Am. J. Cardiol. 2004) 3 4 23 48
  3. Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation. (PMID: 19427440) Brauch K.M. … Olson T.M. (Am. J. Cardiol. 2009) 3 4 23 48
  4. The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome. (PMID: 19401371) Urbanek M. … Dunaif A. (J. Clin. Endocrinol. Metab. 2009) 3 23 48
  5. Mutations in the LMNA gene do not cause axonal CMT in Czech patients. (PMID: 19424285) LassuthovA! P. … Seeman P. (J. Hum. Genet. 2009) 3 23 48

Products for LMNA Gene

  • Addgene plasmids for LMNA

Sources for LMNA Gene

Back to Top

Content